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Abstract
Pregnancy depends on the wholesale transformation of the endometrium, a process
driven by differentiation of endometrial stromal cells (EnSC) into specialist decidual
cells. Upon embryo implantation, decidual cells impart the tissue plasticity needed to
accommodate a rapidly growing conceptus and invading placenta, although the
underlying mechanisms are unclear. Here we characterize a discrete population of
highly proliferative mesenchymal cells (hPMC) in midluteal human endometrium,
coinciding with the window of embryo implantation. Single-cell transcriptomics dem-
onstrated that hPMC express genes involved in chemotaxis and vascular transmigra-
tion. Although distinct from resident EnSC, hPMC also express genes encoding
pivotal decidual transcription factors and markers, most prominently prolactin. We
further show that hPMC are enriched around spiral arterioles, scattered throughout
the stroma, and occasionally present in glandular and luminal epithelium. The abun-
dance of hPMC correlated with the in vitro colony-forming unit activity of midluteal
endometrium and, conversely, clonogenic cells in culture express a gene signature
partially conserved in hPMC. Cross-referencing of single-cell RNA-sequencing data
sets indicated that hPMC differentiate into a recently discovered decidual subpopula-
tion in early pregnancy. Finally, we demonstrate that recurrent pregnancy loss is
associated with hPMC depletion. Collectively, our findings characterize midluteal
hPMC as novel decidual precursors that are likely derived from circulating bone
marrow-derived mesenchymal stem/stromal cells and integral to decidual plasticity in
pregnancy.
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1 | INTRODUCTION
The uterine mucosa—the endometrium—is a highly regenerative tissue
capable of adopting different physiological states during the reproductive
years.1,2 In the midluteal phase of the menstrual cycle, the endometrium
starts remodeling intensively in response to elevated progesterone levels
and rising intracellular cyclic AMP levels,3 heralding the start of a short
window during which an embryo can implant.4 This process, termed
decidualization, begins with an acute stress response in endometrial stro-
mal cells (EnSC),5 resulting in cell cycle arrest, release of proinflammatory
mediators, and influx of uterine natural killer (uNK) cells.6,7 After a lag
period of approximately 4 days, phenotypic decidual cells emerge, coin-
ciding with the closure of the implantation window.6-8 Decidual cells
are progesterone-dependent secretory cells with a well-developed endo-
plasmic reticulum and enlarged nuclei. They are refractory to oxidative
and metabolic stress signals,9-12 and form a quasi-autonomous, anti-
inflammatory matrix around the implanting embryo, which enables
invading extravillous trophoblast to form a hemochorial placenta.3 In
addition, the maternal decidua creates a tolerogenic microenvironment
that harbors an abundance of infiltrating immune cells, foremost uNK
cells but also macrophages, dendritic cells, and regulatory T cells.13
Recently, we provided evidence that inflammatory reprogramming
of EnSC also leads to the emergence of senescent decidual cells.6,8,14
Unlike decidual cells, senescent decidual cells are progesterone resis-
tant.8 They secrete a complex mixture of extracellular matrix (ECM)
proteins and proteinases, proinflammatory cytokines, and chemokines,
designated senescence-associated secretory phenotype (SASP), which
causes sterile inflammation and induces secondary senescence in
neighboring decidual cells.6,8 Hence, in a non-conception cycle, falling
progesterone levels during the late-luteal phase result in a preponder-
ance of senescent decidual cells, an influx of neutrophils, ECM break-
down, and menstrual shedding of the superficial endometrial layer.15
By contrast, continuous progesterone signaling upon successful embryo
implantation enables decidual cells to engage and activate uNK cells,
which in turn target and eliminate senescent decidual cells through
perforin- and granzyme-containing granule exocytosis.6,8 Perturbations
that lead to an excessive or persistent pro-senescent decidual response
presents the embryo with a uterine mucosa that is easy to invade but
also prone to breakdown. Clinically, a pro-senescent decidual response
is associated with rapid conceptions (ie, “super-fertility”) and recurrent
pregnancy loss.8,16,17
Despite these emerging insights, it remains unclear how the maternal
decidua acquires the necessary plasticity to accommodate rapid expansion
in early gestation. Studies in mice have provided compelling evidence that
pregnancy is associated with engraftment of circulating bone marrow-
derived mesenchymal stem/stromal cells (BDMSC) into the decidua,18-20
which differentiate into nonhematopoietic prolactin-expressing decidual
cells.20 A recent study demonstrated that bone marrow transplants from
wild-type mice to mice carrying a heterozygous deletion of Hoxa11, a piv-
otal decidual transcription factor, not only restore the decidual response
but also prevent pregnancy loss in these animals.20 This observation both
underscores the importance of BDMSC in establishing a robust placental-
decidual interface and signposts a novel strategy for the prevention of
intractable pregnancy disorders, such as recurrent pregnancy loss and
preterm birth. Whether BDMSC contribute to the decidual transfor-
mation of human endometrium is, however, not known.
Based on single-cell transcriptomics, we recently described the
presence of a discrete population of highly proliferative mesenchymal
cells (hPMC) in midluteal endometrium.8 Here, we report on the char-
acterization of these cells. Our findings indicate that hPMC are the
human equivalent of bone marrow-derived decidual precursor cells in
mice. We provide evidence that hPMC impart clonogenicity of mid-
luteal endometrium and give rise to a distinct subpopulation of decid-
ual cells at the maternal-fetal interface in pregnancy. We further
demonstrate that a lack of these novel human decidual precursor cells
is associated with recurrent pregnancy loss.
2 | MATERIALS AND METHODS
2.1 | Endometrial sample collection
The collection of endometrial biopsies was approved by the NHS
National Research Ethics—Hammersmith and Queen Charlotte's &
Chelsea Research Ethics Committee (REC reference: 1997/5065) and
Tommy's National Reproductive Health Biobank (REC reference:
18/WA/0356). Samples were obtained using a Wallach Endocell sam-
pler 5 to 10 days after the pre-ovulatory luteinizing hormone
(LH) surge. Demographic details of the tissue samples used in differ-
ent experiments are shown in Table S1.
2.2 | Endometrial tissue processing, primary cell
culture, and CFU assay
Processing of endometrial biopsies, isolation of sushi domain con-
taining 2 (SUSD2)-positive cells using magnetic-activated cell sorting,
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and culturing of primary endometrial cells were carried out as
described in our published step-by-step protocol.21 CFU assays were
also performed as described previously.22 Briefly, EnSC were seeded
at a clonal density of 30 cells/cm2 on 1 mg/mL fibronectin-coated
6-well plates and cultured in 10% DMEM/F12 medium supplemented
with basic fibroblast growth factor (bFGF; 10 ng/mL; Merck Millipore,
Watford, UK) for 10 days with a 50% media change on day 7. Colonies
were monitored microscopically to ensure that they were derived
from single cells. After 10 days, colonies were washed with PBS and
fixed in 4% formaldehyde for 10 minutes at room temperature
(RT) before staining with hematoxylin for 4 minutes. Colonies were
visualized on EVOS FL AUTO microscope (Life Technologies, Paisley,
UK). Clusters of ≥50 cells were counted and cloning efficiency (%)
was calculated as the number of colonies formed/number of cells
seeded ×100.
2.3 | Immunohistochemistry
Endometrial biopsies were fixed overnight in 10% neutral buffered
formalin at 4C and embedded in Surgipath Formula “R” paraffin using
the Shandon Excelsior ES Tissue processor (Thermo Fisher Scientific).
Tissues were sliced into 3 μM sections on a microtome and adhered
to coverslips by overnight incubation at 60C. Deparaffinization, anti-
gen retrieval, antibody staining, hematoxylin counter stain and DAB
color development were fully automated in a Leica BondMax
autostainer (Leica BioSystems). Tissue sections were labeled for anillin
(AMAB90660, Sigma) using a 1:100 dilution. Stained slides were de-
hydrated, cleared and cover-slipped in a Tissue-Tek Prisma Auto-
mated Slide Stainer, model 6134 (Sakura Flinetek, Inc, California) using
DPX coverslip mountant. Bright-field images were obtained on a
Mirax Midi slide scanner with a 20× objective lens, and three ran-
domly selected areas of interest underlying the luminal epithelium
were captured using Panoramic Viewer v1.15.3 (3DHISTECH Ltd,
Budapest, Hungary). Each field was divided manually into three com-
partments: stroma, glandular epithelium, and luminal epithelium.
ImageJ image analysis software (Rasband, W. S., ImageJ, National
Institutes of Health) was used to quantify anillin+ cells with staining
intensity manually determined by background thresholding. The per-
centage of anillin+ cells was calculated (ie, anillin+ cells/total cells
×100) in each field of view and for each cellular compartment.
2.4 | Immunofluorescence microscopy
CFUs and EnSC monolayers in 6-well plates were fixed in 4% parafor-
maldehyde, permeabilized with 0.5% Triton X-100 (Sigma Aldrich) and
blocked with 1% BSA/PBS. Cells were probed with mouse anti-anillin
monoclonal primary antibody (1:100, Sigma-Aldrich) overnight at 4C.
Labeled cells were stained with Alexa-Fluor 594 anti-mouse second-
ary antibody (1:1000, Invitrogen) for 1 hour at RT and counterstained
with VECTASHIELD antifade mounting medium with DAPI (Vector
Laboratories, Peterborough, UK). Images were captured on an EVOS
FL AUTO fluorescence microscope. Anillin+ cells were quantified in
three randomly selected fields relative to total number of DAPI-
stained cells using ImageJ image analysis software. Tissue sections were
double labeled overnight at 4C with antibodies against anillin (mouse
or rabbit) and either CD34 (1:250, Abcam, Cambridge, UK), CD56
(1:200, Leica Biosystems), or CD163 (1:200, Abcam). Labeled cells were
stained with Alexa Fluor 594 anti-mouse secondary antibody and Alexa
Fluor 488 anti-rabbit secondary antibody. Tissue autofluorescence was
eliminated using the TrueVIEW autofluorescence quenching kit (Vector
Laboratories). Tissue sections were stained with ProLong Gold antifade
mounting medium with DAPI (Invitrogen) and examined using an EVOS
FL Auto fluorescence microscope (Life Technologies).
2.5 | RNA-sequencing and analysis
Total RNA was extracted from CFUs and standard cultures using the
AllPrep DNA/RNA Micro Kit (Qiagen, Manchester, UK) following
the manufacturer's protocol. RNA concentration was assessed using
the Qubit RNA BR assay and RNA quality was analyzed on an Agilent
2100 Bioanalyzer (Agilent Technologies). Libraries were prepared
using the TruSeq RNA Library preparation kit V2 (Illumina, Cambridge,
UK) and sequenced on HiSeq 4000 (Illumina) with 75 bp paired-end
reads at the Wellcome Trust Centre for Human Genetics (Oxford,
UK). Transcriptomic maps of paired-end reads were generated using
Bowtie-2.2.3, Samtools-0.1.19, and Tophat-2.0.12 against the hg19
reference transcriptome. Transcript counts were assessed by HTSeq-
0.6.1 using the reverse strand setting and intersection nonempty
mode and counts were assigned to Ensembl gene IDs. Differential
gene expression was evaluated with the DESeq2 package v1.28.1 in R,
using the Wald test and Benjamini and Hochberg FDR corrected
P < 0.05. Principal component analysis on the log2-normalized count
data was performed in MATLAB R2020b. RNA-seq library were analyzed
using Euclidean distance were plotted with pheatmap package v1.0.12 in
R. RNA-seq data were deposited in the Gene Expression Omnibus
(http://www.ncbi.nlm.nih.gov/geo/), accession number GSE159266.
2.6 | Single-cell transcriptome analyses
Analysis of previously reported single-cell RNA-seq data of midluteal
endometrial biopsies (GSE127918) was performed with Seurat R pack-
age v3.2.2. To minimize artifacts, only cells with between 200 and
6000 features and less than 5% mitochondrial gene content were
included in our analysis. Single cells were assigned to phases of the cell
cycle using the CellCycleScoring function using validated cell cycle
marker genes.23 Following scaling and regression of the cell cycle infor-
mation, the first 10 principal components were used to find clusters
using a resolution of 0.4. Marker genes were obtained with the Fin-
dMarkers function with Bonferroni correction. Heatmaps of gene
expression were generated with the gplots package v3.1.0. Ligand-
receptor analyses were performed with CellphoneDB (www.
CellPhoneDB.org).24 Single cell transcriptome data of the maternal-fetal
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F IGURE 1 Legend on next page.
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interface were obtained from ArrayExpress (E-MTAB-6701). Cell cycle
phases were assigned as described above, but not regressed. Differen-
tial gene expression analysis was performed using the published cell
labels. Informative genes were visualized using an on-line browsing tool
(https://maternal-fetal-interface.cellgeni.sanger.ac.uk/).
2.7 | Statistical analysis
Data analyses were performed using the statistical package Graphpad
Prism 6 and R v4.0.2. Mann-Whitney U test, Student t-test, and one-
way ANOVA on ranks (Kruskal-Wallis) test were used as appropriate.
Spearman rank-order correlation coefficient was calculated to mea-
sure the strength and direction of association between two variables.
P < .05 was considered statistically significant.
3 | RESULTS
3.1 | Characterization of hPMC in midluteal
endometrium
We recently reported on single-cell RNA-sequencing analysis of mid-
luteal endometrial biopsies, that is, coinciding with the window of
implantation.8 A notable observation was the presence of a discrete
cell population comprising 1.8% of all nonimmune stromal cells. This
population was designated “highly proliferating mesenchymal cells”
(hPMC) based on 127 upregulated genes (FDR corrected P < .05)
involved in cell cycle progression. In agreement, gene ontology analy-
sis yielded terms such as “cell cycle” (FDR corrected P = 6.3 × 10−66),
“cell division” (FDR corrected P = 4.77 × 10−41), and “regulation of
mitotic cell cycle” (FDR corrected P = 1.41 × 10−22). To explore the
nature of hPMC, we first computationally determined the cell cycle
status of all cells in midluteal endometrium (Figure 1 A). The hPMC
population consisted exclusively of cells in either S-phase (40%) or
G2/M-phase (60%) (Figure 1A). By contrast, the majority of EnSC and
endometrial epithelial cells (EpC) were assigned to G1 (55% and 63%,
respectively). The abundance of endothelial cells (EC) and immune
cells (IC) in S or G2/M phase was 58% and 72%, respectively
(Figure 1 A). Next, we compared gene expression in hPMC assigned
to the G2/M phase to all other cells in G2/M across different
populations. This analysis yielded 19 differentially expressed cell
cycle genes (FDR corrected P < .05), all markedly upregulated in
hPMC (Figure 1B and Table S2). To determine the provenance of
hPMC, we constructed a correlation matrix heatmap and dendro-
gram to show hierarchical clustering of different endometrial cell
populations (Figure 1C). The heatmap depicts the Euclidian distance
in gene expression between cell populations whereas the distance
between the dendrogram branches reflects clustering according to
the complete linkage method. hPMC clustered with EC and EnSC,
but not with EpC or IC, suggesting shared provenance (Figure 1C).
Mining of gene expression data showed that hPMC do not
express genes that encode for canonical IC, EC, or EpC markers
(Figure 1D). They also do not express several EnSC-specific genes
that are constitutively expressed across the menstrual cycle (eg,
ADAMTSL5, PAGE4, APOLD1, and LLGL1) (Figure 1D and Figure S1).
These EnSC-specific marker genes are abundantly expressed, ren-
dering it unlikely that lack of expression in hPMC is an erroneous
observation attributable to relative enrichment of cell cycle genes
in this subpopulation. Furthermore, hPMC share with EnSC the
expression of multiple decidual genes, including DCN (coding
decorin), DKK1 (dickkopf WNT signaling pathway inhibitor 1), IL15
(interleukin 15), and TIMP3 (TIMP metallopeptidase inhibitor 3).8
PRL (prolactin), a widely used marker gene of decidualizing
EnSC in vitro,3 is conspicuously enriched in hPMC in vivo. Another
notably enriched decidual gene is IL1RL1, which codes both the
transmembrane and soluble IL-33 receptors (termed ST2L and
sST2, respectively).7 hPMC also express key decidual transcription
factors, including PGR (coding the progesterone receptor),25
HAND2 (heart and neural crest derivatives expressed 2),26 and
HOXA11 (homeobox A11),27 indicating commitment to decidual dif-
ferentiation (Figure 1D). On the other hand, hPMC share with IC
genes involved in chemotaxis (eg, CXCR4 and KIT) and trans-
endothelial migration (eg, ITGA4 and CD82).28 However, unlike IC,
hPMC also express genes coding for secreted factors implicating in
MSC self-renewal and engraftment (Figure 1D), including tropo-
elastin (ELN),29 pleiotrophin (PTN),30 and cellular communication
network factor 3 (CCN3).31 Next, we used CellPhoneDB to explore
putative interactions between hPMC, EC and EnSC. This computa-
tional tool takes into account the subunit architecture of both
ligands and receptors in heteromeric complexes.13,24 As shown
in Figure 1E and Table S3, CellPhoneDB predicted many more
enriched receptor-ligand interactions between EC and hPMC
than with EnSC. Specifically, hPMC selectively encode ligands that
bind various EC receptors, including NOTCH 1, 3 and 4, TIE2
receptor (TEK), and VEGFR (KDR). On the other hand, activation of
F IGURE 1 Transcriptomic analysis of hPMC. A, Top panel shows t-SNE projection of mid-secretory endometrial cell populations [epithelial
cells (EpC), immune cells (IC), endothelial cells (EC), stromal cells (EnSC) and highly proliferative mesenchymal cells (hPMC)] color-coded to
indicate cells in different phases of the cell cycle (G1, S and G2/M). Lower panel shows the proportion of cells in the different phases of the cell
cycle for each population. B, Violin plots showing the relative expression in G2/M phase of six genes highly enriched in hPMC. FDR corrected
P-values are also shown. C, Heatmap showing Euclidean distance between different cell populations based on average expression values. D,
Heatmap showing relative expression (z-score) of genes used to characterize hPMC. Red and blue represent high and low gene expression,
respectively, as indicated by the color key. E, Overview of selected ligand-receptor interactions generated by Cellphone DB tool. FDR corrected
P-values are reflected by circle sizes. The means of the average expression level of interacting molecule 1 in cluster 1 and interacting molecule
2 in cluster 2 are indicated by the color key
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insulin-like growth factor 1 receptor (IGF1R) is predicted to play a
role in chemotaxis of hPMC within the stromal compartment (Figure 1E).
Intriguingly, a recent study reported activation of IGF1R by CXCL14,32
an orphan chemokine abundantly expressed in midluteal endometrium.33
Taken together, the data suggest that hPMC are trans-endothelial migra-
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F IGURE 2 Spatiotemporal distribution of anillin+ cells in peri-implantation endometrium. A, Examples of anillin+ cells in endometrial stroma
and glandular and luminal epithelium. Scale bar = 20 μm. B, Quantification of anillin+ cells in different endometrial compartments during the early-
(LH + 5/6), mid- (LH + 7/9), and late-secretory (LH + 10/11) phase of the cycle. The number of biopsies analyzed at each timepoint is indicated.
Different letters above box plots indicate that groups are significantly different from each other at P < .05 (one-way ANOVA on ranks test). C,
Spearman's rank correlation of anillin+ cells in endometrial stroma, glandular epithelium and luminal epithelium. D, Quantification of anillin+CD34+
hematopoietic/endothelial precursor cells, anillin+CD163+ macrophages, and anillin+CD56+ uNK cells in peri-implantation endometrium. Different
letters above the box plots indicate that groups are significantly different from each other at P < .05 (one-way ANOVA on ranks test). E, Relative
proportions of anillin+ IC and hPMC (nonimmune anillin+ cells) during the midluteal window of implantation (LH + 7/9) and late-secretory phase
(LH + 11)
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3.2 | Spatiotemporal distribution of hPMC in luteal
phase endometrium
Cross-referencing of potential hPMC markers with the Human Protein
Atlas (http://www.proteinatlas.org) revealed the presence of rare anillin+
cells scattered throughout the endometrium.34 Anillin, encoded by ANLN,
is an actin-binding protein involved in cytokinesis, cell growth and migra-
tion.35 To examine if anillin could serve as a marker for hPMC, immunohis-
tochemistry was performed on 61 LH-timed endometrial biopsies
obtained across the luteal phase. This analysis confirmed that anillin+ cells
are rare and dispersed throughout the stroma, although frequently
enriched around the terminal spiral arterioles (Figure 2A). Unexpectedly,
some anillin+ cells were also found in glandular and luminal epithelium
(Figure 2A). The average abundance of anillin+ cells [median (interquartile
range, IQR)] in the stromal compartment across the luteal phase was 0.6
(1.3)% vs 0.4 (0.7)% and 0.2 (0.6)% in the luminal and glandular epithelium,
respectively. In contrast to glandular or luminal epithelium, anillin+ cells
increased significantly in the stroma upon progression from early to late-
secretory phase of the cycle (Figure 2B). Quantification of anillin+ cells
showed a strong correlation between the three main cellular compart-
ments (Figure 2C), especially between the stroma vs glandular epithelium
(r = 0.7, P < .0001, Spearman's rank test) and glandular vs luminal epi-
thelium (r = 0.7, P < .0001). Nevertheless, proportionally many more
anillin+ cells reside in the stroma when compared with glandular or
luminal epithelium (Figure S2).
We reasoned that the time-dependent increase in anillin+ cells in the
stroma could be accounted for by accumulation of proliferating uNK cells
or macrophages prior to menstrual shedding.15 To test this conjecture,
21 endometrial biopsies were subjected to double-labeling immunofluo-
rescence microscopy to quantify co-expression of anillin with CD163 or
CD56, macrophage and uNK cell markers, respectively.6,36 To assess the
contribution of proliferating leukocyte and EC precursors, the abundance
of anillin+ cells co-expressing CD34 was also quantified (Figure S3).37
The samples were selected to coincide with the implantation window
(LH + 7 and LH + 9) or the late-secretory phase of the cycle (LH + 11).
Anillin+ CD56+ cells were noticeably absent in all but one sample at
LH + 7 but their abundance increased markedly upon transition to the
late-secretory phase in parallel with anillin+CD163+ macrophages
(Figure 2D). The reverse pattern was observed for anillin+CD34+ cells. At
the start of the implantation window (LH + 7), 61% of anillin+ cells did
not express IC markers, but this dropped to 32% by the late-secretory
phase of the cycle (Figure 2E).
3.3 | hPMC confer endometrial clonogenicity
To determine if hPMC confer endometrial clonogenicity, we first
established paired colony forming unit (CFU) assays and standard pri-
mary EnSC cultures from three biopsies (Figure 3A). After 7 days, the
abundance of anillin+ cells [median (IQR)] in standard cultures was 1.7
(1.9)% vs 17 (7.7)% in clonal assays (P < .05, Mann Whitney U test). To
test whether culturing leads to loss of proliferative capacity, anillin+ cells
were quantified using immunofluorescence microscopy in CFU assays
after 3, 6, or 9 days in culture (Figure 3B). Notably, the abundance of
anillin+ clonal cells on day 3 was 68 (17.7)% but this dropped significantly
by day 9 to 15.1 (9.6)% (P < .0002, Kruskal-Wallis test). Next, we exam-
ined if the abundance of anillin+ cells in vivo is a measure of endometrial
clonogenicity. CFU assays were established from 47 midluteal endome-
trial biopsies and, in parallel, anillin+ cells were quantified in the stromal
compartment using immunohistochemistry (Figure 3C). A significant cor-
relation was observed between the percentage of anillin+ stromal cells
in vivo and CFU activity of freshly isolated EnSC in vitro (r = 0.49,
P < .0004, Spearman's rank test).
3.4 | Transcriptomic profiling of cultured
clonogenic and resident stromal cells
Previous studies reported that CFU assays are more efficient when
established from SUSD2+ perivascular cell (PVC) fraction when
F IGURE 3 hPMC confer clonogenicity to midluteal superficial endometrium. A, Percentage of anillin+ cells in primary EnSC cultures and CFU
assays. Bar graphs show median of three biological repeat experiments. B, Percentage of anillin+ cells in CFU assays on day 3, 6, and 9 of culture.
Bar graphs show median of four biological repeat experiments. Different letters above the box plots indicate that groups are significantly
different from each other at P < .05 (one-way ANOVA on ranks test). C, Spearman's rank correlation of anillin+ cells in the endometrial stromal
compartment in vivo and CFU activity of freshly isolated EnSC in 47 paired midluteal endometrial biopsies
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F IGURE 4 A shared gene signature between clonogenic cells in culture and hPMC in vivo. A, Schematic depiction of the experimental design.
After 10 days in culture, total RNA from three biological repeat experiments was subjected to bulk RNA-sequencing. B, Principal-component
analysis of RNA-seq data of cultured clonogenic cells (eMSC/TA) and resident cells (EnSC/PVC). C, Upper panels: box plots showing relative
expression in eMSC vs EnSC or eMSC vs PVC of genes either enriched or depleted in hPMC when compared with EnSC. Lower panel: box plot
showing relative expression in hPMC vs EnSC of genes either significantly enriched or depleted in eMSC when compared with EnSC and PVC.
For in vitro bulk RNA-seq data, DEGs were defined as >2-fold-change (FC) and FDR corrected P < .05. For in vivo scRNA-seq data, DEGs were
defined as P < .05 and expression in >10% of cells. D, Composite heatmap showing relative expression of indicated genes in EC, EnSC and hPMC
in vivo and eMSC, TA cells, EnSC and PVC in vitro. The color key indicates the level of gene expression relative to the highest expressing cell
population in vivo or in vitro
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compared with non-perivascular (SUSD2−) EnSC.22,38 We reasoned
that if hPMC are derived from circulating progenitor cells and account
for endometrial clonicity during the implantation window, the trans-
criptomic profiles of clonogenic cells in culture should exhibit less vari-
ability when compared with cultured resident PVC or EnSC that have
been exposed to iterative menstrual cycles in vivo. To test this hypothe-
sis, we used magnetic-activated cell sorting to isolate SUSD2+ PVC and
SUSD2− EnSC from three different biopsies and subjected both cell
fractions to standard cultures as well as CFU assays (Figure 4 A). For
clarity, clonogenic cells established from PVC were termed endometrial
MSC (eMSC) whereas the term “transit amplifying” (TA) cells was
coined to clonal cells in the EnSC fraction. After 10 days in culture, total
RNA was extracted and subjected to RNA-seq analysis. Principal com-
ponent (PC) analysis separated standard EnSC and PVC cultures from
eMSC and TA in PC1 (Figure 4B). Notably, all six libraries from clonal
cells clustered tightly together. Although PVC and EnSC also clustered
together, there was considerable divergence in their transcriptional pro-
files between samples (Figure 4B). Thus, in keeping with our hypothesis,
cultured resident cells exhibit much greater interpatient transcriptional
variability when compared with clonogenic cells.
Based on >2-fold-change in gene expression and FDR corrected
P < .05, only two transcripts (STMN3 and ITGBL1) were differentially
expressed between eMSC and TA cells, indicating shared origins.
By contrast, 3460 genes were differentially expressed between
clonogenic cells (eMSC plus TA cells) and resident stromal cells (PVC
plus EnSC). Out of the 3460 genes, 81.8% were down-regulated in
clonal cells. The heatmap in Figure S4A depicts the 10 most highly
enriched or depleted genes in clonal cells when compared with EnSC
and PVC. In keeping with the results of a previous study,38 a total of
216 differentially expressed genes (DEG) were identified between
cultured PVC and EnSC. Interesting, some genes enriched in PVC vs
EnSC appeared also higher expressed in eMSC and, to a lesser extent,
in TA cells, although statistical significance was often not reached
(Figure S4A). An UpSet plot was used to depict the intersections of
DEG in different comparisons (Figure S4B).
Clonogenic cells rapidly undergo spontaneous differentiation and
senescence in culture.39 Nevertheless, differences in gene expression
between hPMC vs EnSC in vivo were partially maintained in eMSC
when compared with EnSC (P = 8.3 × 10−16, t-test) or PVC
(P = 1.4 × 10−22) in vitro (Figure 4C and Table S4). Conversely, differ-
ences in gene expression between clonal and resident cells in vitro
were also partially maintained between hPMC and EnSC in vivo
(P = 6.1 × 10−19) (Figure 4C). Mining of the data provided further
evidence that hPMC are the progenitors of colony-forming cells in
culture. As anticipated, proliferation-associated genes were higher
expressed in eMSC/TA cells when compared with cultured EnSC or
PVC (Figure 4D), including multiple genes implicated in cancer stem
cells (eg, PBK, NUSAP1, MELK, CDC20, and ASPM).40-43 Furthermore,
several MSC-related genes enriched in hPMC were also selectively
enriched in eMSC/TA cells. For example, ALDH1L1, encoding alde-
hyde dehydrogenase 1 family member L1, and CD109 are putative
biomarkers of cancer stem-like cells,44,45 whereas profilin 2 (PFN2)
promotes migration, invasion and stemness of HT29 human colorectal
cancer stem cells.46 Matrix metallopeptidase 16 (MMP16) controls the
migration of human cardiomyocyte progenitor cells.47 Notably, eMSC,
and to a lesser extent TA cells, also express an EC-like gene signature,
albeit devoid of canonical endothelial marker genes (Figure 4D). Multi-
ple genes in this signature, such as SKP2, ITGA8, SLIT2, and SOX9,
have been shown to be implicated in different stem/progenitor cell
niches.48-51
3.5 | Loss of hPMC in recurrent pregnancy loss
We reported previously that recurrent pregnancy loss, defined here as
three or more miscarriages, is associated with loss of eMSC and TA
cells, as assessed by CFU assays on freshly isolated PVC and EnSC,
respectively, from midluteal biopsies.14 Hence, we examined if this
prevalent reproductive disorder is also associated with loss of anillin+
hPMC in vivo. To mitigate against interference from anillin+ IC, the
analysis was restricted to endometrial biopsies obtained on LH + 7, a
timepoint when anillin+ CD56+ cells are virtually absent (Figure 2D). A
total of 30 biopsies from RPL patients (n = 15) and control subjects
(n = 15) were processed for immunofluorescence microscopy to
F IGURE 5 Loss of hPMC in recurrent pregnancy loss (RPL). The percentage of anillin+ cells co-expressing, A, CD163 (macrophages) or, B,
CD34 (hematopoietic/endothelial precursor cells) was quantified by immunofluorescent microscopy in endometrial biopsies obtained on LH + 7
from control subjects (n = 15) and RPL patients (n = 15). C, The relative abundance of hPMC (ie, anillin+ cells not co-expressing CD34 or CD163)
in endometrial biopsies from control and RPL subjects. * indicates P < .05 (Mann-Whitney U test)
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quantify anillin+ cells in the stromal compartment as well anillin+ cells
co-expressing CD163 or CD34. While the percentage of ani-
llin+CD163+ cells did not differ between the two clinical groups
(Figure 5A), a significant increase in anillin+CD34+ cells was observed
in RPL patients when compared with control subjects (P < .05, Mann-
Whitney test; Figure 5B). Conversely, RPL was associated with a
F IGURE 6 hPMC are putative precursors of a distinct decidual subpopulation in pregnancy. A, Upper panel: box plots showing the relative expression
in dS3 vs dS1 and dS2 subpopulations of genes either significantly (P < .05 and expression in >10% of cells) enriched or depleted in hPMCwhen compared
with EnSC and EC in midluteal endometrial. Lower panel: box plots showing the relative expression in hPMC vs EnSC of genes either significantly enriched
or depleted in dS3 cells when compared with dS1 and dS2 populations at the maternal-fetal interface in early pregnancy. B, Composite heatmap showing
relative expression of indicated genes in the three decidual subsets (dS1-3) at the maternal-fetal interface in early gestation and in EnSC and hPMC during
the window of implantation. Annotated genes were color-coded to indicate stress-related genes (red), mitochondrial and metabolic genes (blue), or genes
coding for known decidual factors (black) or transcription factors (bold black). The color key indicates the level of gene expression relative to the highest
expressing cell population either in pregnancy (dS1-3) or during the implantation window prior to conception (EnSC and hPMC)
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reciprocal reduction in hPMC, that is, anillin+ cells that do not express
IC markers (P < .05, Mann-Whitney U test; Figure 5C). The abundance
of hPMC population was noticeably more variable in tissue samples
from RPL patients when compared with control subjects (Figure 5C).
Furthermore, hPMC made up >50% of all anillin+ cells in 14 out of
15 control samples compared with only 7 out of 15 samples in the
RPL group (P = .01, Fisher's exact test).
3.6 | hPMC map to a distinct decidual
subpopulation in pregnancy
Next, we set out to determine the potential fate of hPMC in early
pregnancy. To do this, we made use of the recently published single-
cell atlas of the maternal-fetal interface in early gestation.13 Anatomi-
cally, the maternal decidua consists of two distinct layers, the decidua
compacta near the surface epithelium and the underlying decidua
spongiosa, which contains hypersecretory glands. The two decidual
layers contain three decidual subpopulations, designated dS1-3
(Figure S5A).13 The decidua spongiosa harbors dS1 cells expressing
ACTA2 whereas the dS2 and dS3 cells in the decidua compacta share
the expression of DCN (Figure S5B). Notably, dS3 cells constitute a
minor subpopulation, representing only 7.2% of all decidual stromal
cells at the maternal-fetal interface. Computational analysis indicated
that 7% of dS3 cells are in S or G2/M phase of the cell cycle com-
pared with 2.6% and 3.1% of dS2 and dS1 cells, respectively. Although
dS3 cells are much less proliferative than hPMC, they nevertheless
share a conspicuous gene signature (Figure 6A and Table S5). This sig-
nature is not only enriched in several canonical decidual genes, includ-
ing PRL, IL1RL1, and CD82 (also known as KAI1),7,25,52 but also in
genes involved in glycolysis and mitochondrial function (Figure 6B
and Figure S5B). Conversely, hPMC in midluteal endometrium and
dS3 cells at the maternal-fetal interface in pregnancy are relatively
depleted in genes implicated in cellular stress responses (Figure 6B),
including members of the AP-1 family of transcription factors (FOS,
FOSB, JUN, and JUNB) and CEBPβ (CEBPB), which effects free radical
signaling in decidual cells.53 Based on this shared metabolic and decid-
ual gene signature, we conclude that hPMC likely give rise in preg-
nancy to a distinct decidual subpopulation that engages with invading
placental trophoblast in the decidua compacta.
4 | DISCUSSION
Decidual transformation of human endometrium upon embryo
implantation requires differentiation of resident EnSC, immune clear-
ance of acute senescent decidual cells, and rapid tissue growth. These
processes occur in concert with coordinated trophoblast invasion.54
Considering the magnitude of tissue remodeling required for preg-
nancy, poised progenitor and highly proliferative decidual precursor
cells are likely critical for the formation of a robust maternal-fetal
interface, as is the case in mice.20 Here, we provide evidence of
recruitment, engraftment, and differentiation of hPMC/decidual
precursor cells during the window of implantation in human endome-
trium. Transcriptional profiling highlighted the transitional nature of
hPMC, exemplified on the one hand by expression of genes involved
in chemotaxis, EC interactions, migration, and engraftment and, on
the other, by expression of decidual transcription factors and marker
genes. Human BDMSC are capable of differentiating into prolactin-
producing decidual cells in vitro,55 further supporting our assertion
that hPMC are equivalent to bone marrow-derived decidual precursor
cells in pregnant mice. We demonstrate that hPMC share a conspicu-
ous gene signature with dS3 cells identified recently in the decidua
compacta of the maternal-fetal interface.13 This common gene signa-
ture is defined by the expression of specific decidual marker genes,
including PRL, IL1RL1, and CD82,7,25,52 enhanced expression of mito-
chondrial and metabolic genes, and the relative lack of stress-related
genes when compared with either resident EnSC in midluteal endo-
metrium or other decidual subsets present at the maternal-fetal inter-
face in pregnancy. Furthermore, a hallmark of dS3 cells in pregnancy
is the expression of HSD11B1,13 which converts inactive cortisone
into cortisol, a potent anti-inflammatory glucocorticoid.56 Although
our computational analysis showed that the proliferative capacity of
dS3 cells is higher than that of other decidual subsets, it is markedly
lower when compared with hPMC. It is plausible that recruitment of
hPMC to the maternal-fetal interface diminishes rapidly upon invasion
and plugging of the maternal terminal arterioles by extravillous tro-
phoblast and subsequent physiological transformation of the spiral
arteries.57-59 If correct, the level of cellular plasticity in the decidual
basalis, and thus protection against decidual senescence throughout
gestation, may be determined during a relatively narrow window in
early gestation.
Studies on the role of BDMSC in endometrial physiology have
largely focused on tissue regeneration.60-62 Menstrual “injury” and ris-
ing estradiol levels upregulate CXCL12, a potent chemotactic factor
that mediates mobilization and homing of BDMSC by activating
CXCR4.63 It is unclear whether the CXCL12/CXCR4 axis also medi-
ates recruitment of BDMSC during the progesterone-dominant luteal
phase. Notably, the expression of the evolutionarily related chemo-
kine CXCL14 is at least a magnitude higher during the window of
implantation when compared with CXCL12.4,8 CXCL14 is an orphan
chemokine acting on uNK cells and immature dendritic cells but not T
cells.64 It also stimulates fibroblast proliferation and migration,65 as
well as embryonic stem cell renewal.32 The peri-implantation endome-
trium is further characterized by increased vascular permeability,66
which arguably facilitates extravasation of circulating hematopoietic
and nonhematopoietic cells. BDMSC also give rise to EC progenitor
cells in both human and murine endometrium.20,62,67,68 This shared
ontogeny with hPMC may account for our observation that clonogenic
cells in culture spontaneously express EC-related genes.
Our characterization of bone marrow-derived decidual precursors
in human endometrium has potentially far-reaching clinical implica-
tions. As mentioned, bone marrow transplantation experiments in
mice provided elegant proof-of-concept evidence of the therapeutic
potential of BDMSC, demonstrating that wild-type BDMSC restore
uterine defects, enhance decidualization, and prevent pregnancy loss
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in Hoxa10+/− mice.20 We reported previously that recurrent preg-
nancy loss is associated with loss of endometrial clonogenicity in midluteal
endometrium, measured by CFU assays on freshly isolated EnSC,14 and
increased frequency of menstrual cycles with a pro-senescent decidual
response.8 We now demonstrate that a lack of decidual precursor cells
accounts for the loss of endometrial clonogenicity in recurrent miscarriage.
A history of miscarriage also increases the risk of preterm birth,69,70 the
leading cause of neonatal death and morbidity worldwide.71 Interestingly,
while recurrent pregnancy loss is associated with an overt pro-senescent
decidual response,8,16 spontaneous preterm labor is linked to accelerated
decidual aging and loss of plasticity at the maternal-fetal interface.72,73
Hence, it is plausible that treatments aimed at enhancing recruitment,
engraftment and differentiation of hPMC in the endometrium prior to, or
soon after, conception will not only reduce the risk of miscarriage but also
prevent preterm labor in at risk women. In this context, a recent pilot trial
demonstrated that sitagliptin, a dipeptidyl-peptidase IV inhibitor used in
the management of diabetes, increases endometrial clonogenicity and
decreases decidual senescence during the implantation window in recur-
rent miscarriage patients.74 The efficacy of sitagliptin, and other potential
interventions that target BDMSC and decidual precursor cells,28 in mitigat-
ing the risk of adverse pregnancy outcome warrants further evaluation in
clinical trials.
5 | CONCLUSION
This study profiles the transcriptome of decidual precursor cells dur-
ing the window of implantation in human endometrium. Based on our
findings, we posit that decidual precursors are derived from circulating
BDMSC, primed for exponential growth in early pregnancy, and inte-
gral to the formation of the decidua compacta of the maternal-fetal
interface. Conversely, lack of decidual precursors in a conception
cycle may trigger a concatenation of events, resulting in breakdown of
the decidua in early gestation and miscarriage or, plausibly, acceler-
ated aging of the maternal-fetal interface and spontaneous preterm
labor.
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